A Study on Time Intervals Between Last Dose of Antagonist Administration & Trigger
Not Applicable
- Conditions
- Health Condition 1: Z314- Encounter for procreative investigation and testing
- Registration Number
- CTRI/2023/08/056365
- Lead Sponsor
- Dr. Aishwarya Parthasarathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age 25 to 38 years.
BMI in range of 18-35.
GnRH antagonist protocol.
Normal hormonal profile as assessed by DAY 2 FSH, TSH, Prolactin, and AMH.
Written consent to participate in trial.
Exclusion Criteria
Hypogonadotropic hypogonadism.
Premature ovarian insufficiency.
Age more than 38 years.
Patients not willing to participate in the trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure & compare oocyte recovery rate, <br/ ><br>M II rates, Fertilization & Blastocyst rate <br/ ><br>Timepoint: Baseline <br/ ><br>
- Secondary Outcome Measures
Name Time Method To measure posterior trigger LH, progesterone concentrations, clinical pregnancy rates, miscarriage rates & ongoing pregnancy ratesTimepoint: Baseline